Cerebral adrenoleukodystrophy presenting as status epilepticus: Unveiling the neurological maze

Saket Satyasham Toshniwal1, S Jiwan Kinkar2, Sunil Kumar1

  • 1Department of General Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India.

Radiology Case Reports
|November 11, 2024
PubMed

Insights

X-linked cerebral adrenoleukodystrophy (ALD) is a rare genetic disorder causing neurological decline. Early detection and intervention are crucial for managing this progressive condition and improving patient outcomes.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Adrenoleukodystrophy (ALD) is a rare X-linked genetic disorder.
  • Caused by ABCD1 gene mutations, it leads to very long-chain fatty acid accumulation.
  • This accumulation damages the spinal cord, white matter, and adrenal glands.

Observation:

  • A 7-year-old boy presented with seizures, visual changes, and progressive neurological decline over 6 months.
  • Brain MRI showed diffuse white matter lesions.
  • Elevated serum ACTH, tetracosanoic acid (C24), and hexacosanoic acid (C26) levels were noted.

Findings:

  • The patient was diagnosed with X-linked cerebral adrenoleukodystrophy.
  • Despite initial stabilization, the patient rapidly progressed to blindness, immobility, and a vegetative state.

Implications:

  • This case underscores the critical need for early diagnosis and intervention in ALD.
  • Increased awareness among healthcare professionals is vital for timely detection.
  • Prompt management can potentially slow disease progression and improve outcomes.